Afghanistan presents medical challenges determined by infrastructure damage from four decades of conflict, limited public health systems outside major cities, and environmental hazards from altitude and climate extremes. No international health organization recommends travel to Afghanistan under current security conditions, but travelers who proceed face a medical environment where emergency evacuation is the primary contingency for serious illness or injury.
The Ministry of Public Health operates through 34 provincial directorates, but functional capacity varies significantly. Kabul maintains the highest concentration of medical facilities, including the French Medical Institute for Mothers and Children, Emergency Hospital operated by the Italian NGO Emergency, and Jamhuriat Hospital. The Emergency Hospital in Kabul provides free trauma and surgical services and maintains international medical standards, though resources remain limited compared to Western facilities. Herat hosts the Herat Regional Hospital and facilities maintained by Italian medical NGOs. Mazar-i-Sharif Regional Hospital serves northern provinces. Kandahar Regional Hospital functions with support from international medical organizations, though security conditions frequently disrupt operations. Outside these centers, medical infrastructure degrades rapidly. Rural Badakhshan province, Nuristan province, and much of Helmand province lack facilities with consistent electricity, sterile surgical capacity, or diagnostic imaging.
Private clinics in Kabul accept international patients but lack trauma surgery capacity and advanced diagnostics. The Cure International Hospital in Kabul specializes in orthopedic surgery. The AKDN-operated clinic in Faizabad serves Badakhshan but focuses on maternal health. No hyperbaric chambers exist in Afghanistan for altitude sickness complications. No cardiac catheterization labs operate outside Kabul. Dialysis capacity exists only in Kabul, Herat, and Mazar-i-Sharif. Blood supply safety remains inconsistent due to limited screening infrastructure.
Medical evacuation represents the standard response to serious illness or injury. No commercial air ambulance services operate regular routes to Afghanistan. International SOS and Global Rescue provide medical evacuation services but require security escorts and military coordination for ground movement to Kabul airport. Evacuation destinations typically include Dubai, Delhi, or Islamabad depending on flight availability and patient stability. Ground evacuation to Pakistan through Torkham gate near Jalalabad requires four to six hours under optimal security conditions. The Wakhan Corridor borders Tajikistan but lacks maintained roads suitable for ambulance transit. Helicopter evacuation exists only through military or NGO assets, availability determined entirely by security conditions. Travelers should verify that insurance policies explicitly cover Afghanistan, as many exclude war zones or require supplemental premiums exceeding $10,000 annually.
Altitude physiology affects travel through the Hindu Kush mountain range and Pamir Mountains. Kabul sits at 1,800 meters elevation. The Salang Pass reaches 3,878 meters and remains the primary route connecting Kabul to northern Afghanistan. Acute mountain sickness symptoms begin for unacclimatized travelers above 2,500 meters. The Wakhan Corridor reaches elevations exceeding 4,000 meters, with valleys between 3,000 and 3,600 meters. Bamiyan town sits at 2,500 meters. No supplemental oxygen supplies exist along mountain routes. The drive from Kabul through the Salang Pass to Mazar-i-Sharif gains elevation rapidly without acclimatization stops. Travelers to Band-e Amir National Park at approximately 2,900 meters should monitor for headache, nausea, and dyspnea. High-altitude pulmonary edema and high-altitude cerebral edema require immediate descent; the nearest facilities capable of managing these conditions are in Kabul or international evacuation. Travelers with cardiac conditions face increased risk above 2,500 meters where myocardial oxygen demand increases.
Infectious disease epidemiology in Afghanistan includes endemic malaria, leishmaniasis, and tuberculosis. The World Health Organization reports malaria transmission throughout Afghanistan below 2,000 meters elevation from May through November, with Plasmodium vivax accounting for 95 percent of cases and Plasmodium falciparum five percent. Risk areas include Nangarhar province, Kunar province, Laghman province, Kandahar province, Helmand province, and the Kunduz river valleys. Kabul elevation exceeds the transmission zone. Prophylaxis options include atovaquone-proguanil, doxycycline, or mefloquine; chloroquine resistance exists throughout Afghanistan. Cutaneous leishmaniasis transmits through sandfly bites in Kabul and all provinces below 2,200 meters. An estimated 67,000 cases occur annually, concentrated in Kabul, Herat, and Balkh. No vaccine exists; DEET-based repellents and permethrin-treated clothing reduce exposure. Visceral leishmaniasis occurs at lower incidence, primarily in northern provinces. Diagnosis requires tissue biopsy unavailable outside Kabul.
Tuberculosis incidence in Afghanistan reached 189 cases per 100,000 population in 2022 according to WHO data. Drug-resistant tuberculosis constitutes approximately nine percent of new cases. Transmission occurs through prolonged indoor exposure; short-term travelers face minimal risk. Testing after potential exposure requires interferon-gamma release assays unavailable in Afghanistan. Crimean-Congo hemorrhagic fever occurs sporadically in livestock-raising regions; the Khost outbreak in 2018 recorded 57 cases with 12 deaths. Transmission follows tick bites or contact with livestock blood. Brucellosis transmits through unpasteurized dairy products, common in rural Afghanistan where refrigeration infrastructure remains limited. Typhoid fever occurs throughout Afghanistan; water chlorination systems function inconsistently. The conjugate typhoid vaccine provides 85 percent protection for three years.
Polio remains endemic in Afghanistan alongside Pakistan. The country reported six wild poliovirus type 1 cases in 2023 according to the Global Polio Eradication Initiative, concentrated in southern provinces where vaccination access faces security restrictions. Vaccination campaigns face opposition in some areas. Adults who completed childhood vaccination should receive a single booster if traveling to Afghanistan. Measles outbreaks occur regularly; in 2019 Afghanistan reported 23,000 measles cases. The MMR vaccine provides reliable protection. Japanese encephalitis does not occur in Afghanistan. Rabies exists throughout the country in dog populations; post-exposure prophylaxis requires rabies immune globulin and vaccine series, available only in Kabul and requiring international evacuation for reliable access. Pre-exposure rabies vaccination eliminates immune globulin requirement and reduces post-exposure doses from four to two.
Hepatitis A transmits through contaminated food and water throughout Afghanistan. The vaccine provides protection after one dose, full immunity after the six-to-twelve-month booster. Hepatitis B prevalence reaches 2.4 percent in the general population, transmission through medical procedures with inadequate sterilization. The vaccine series requires six months to complete; accelerated schedules exist. Hepatitis E occurs in waterborne outbreaks, particularly affecting pregnant women; no vaccine is available outside China. Cholera outbreaks follow seasonal patterns in provinces with damaged water infrastructure. The oral cholera vaccine provides 65 percent protection for two years but remains unavailable in many markets.
Routine vaccinations require updating before Afghanistan travel. Tetanus-diphtheria boosters last ten years. Pertussis immunity wanes; adults should receive Tdap if more than ten years from last dose. Varicella immunity requires two documented doses or serologic proof. Influenza circulates year-round with peaks in winter months. Pneumococcal vaccination protects against bacterial pneumonia in travelers over 65 or with chronic lung disease. Meningococcal disease occurs sporadically; the quadrivalent conjugate vaccine covers serogroups A, C, W, and Y. COVID-19 vaccination requirements shift based on current regulations; Afghanistan does not maintain entry testing requirements as of 2024, but transit countries may impose restrictions.